✦ LIBER ✦

Response to second-line chemotherapy in patients with metastatic breast carcinoma previously responsive to first-line treatment : Prognostic factors

✍ Scribed by Bernard Brun; Mohamed Benchalal; Christelle Lebas; Pascal Piedbois; Ma Lin; Jean-Paul Lebourgeois

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 95 KB
Volume: 79
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19970601)79:11<2137::aid-cncr11>3.0.co;2-x

No coin nor oath required. For personal study only.

✦ Synopsis

tic factors associated with response to a second-line chemotherapy in patients with metastatic breast carcinoma (MBC) that was previously responsive to a first-

📜 SIMILAR VOLUMES

Glutathione concentration may be a usefu

Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer

✍ Junzo Kigawa; Yukihisa Minagawa; Yasunobu Kanamori; Hiroaki Itamochi; Xiusi Chen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

in tumor samples was determined by immunohistochemical staining and Western blot analysis. GSH concentration was measured by an enzymatic assay. Department of Obstetrics and Gynecology, Tot- ## RESULTS. The response rate was 38.4%. The estimated 3-year survival rate for tori University School of

Topoisomerase-I activity and response to

Topoisomerase-I activity and response to second-line chemotherapy consisting of camptothecin-11 and cisplatin in patients with ovarian cancer

✍ Junzo Kigawa; Masakuni Takahashi; Yukihisa Minagawa; Tetsuro Oishi; Toru Sugiyam 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB 👁 2 views

The aim of the present study was to clarify the relationship between topoisomerase-I (topo-I) activity and sensitivity to second-line chemotherapy consisting of cisplatin and camptothecin-11 (CPT-11) in patients with ovarian cancer. Thirty Japanese women with relapsed epithelial ovarian cancer who r

Responsiveness of patients with advanced

Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A gynecologic oncology group study of second-line therapy in 105 patients

✍ Kenneth D. Hatch; Jackson B. Beecham; John A. Blessing; William T. Creasman 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 1 views

Prognostic features and outcome in patie

Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens

✍ Luis Villela; Armando López-Guillermo; Silvia Montoto; Susana Rives; Francesc Bo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB